MERCK Kommanditgesellschaft auf Aktien(0O14)
EUR --+0.00%
Reward55Moderate
Risk19Low
📊50%Data
0O14
+0.0 · +0.00%
EUR · LSE
MERCK Kommanditgesellschaft auf Aktien |
Defensive Anchor
Market Cap:24.61Bn
ℹ️
Reward Rating
55
Moderate
Bottom 50% (model universe)
50% data coverage
ℹ️
Risk Rating
19
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0O14 to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is MERCK Kommanditgesellschaft auf Aktien?

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.

0O14 · Verdict

Solid reward · low risk

0O14 scores well on cash flow and balance sheet with no major weaknesses flagged in the model.

Based on 75% data coverage

0O14 · Verdict

What’s working & what to watch

Strengths 4

  • Cash flow95/100

    Top decile vs peers

  • Balance sheet80/100

    Current ratio 1.28

  • Profitability66/100

    9% return on equity

  • Volatility65/100

    Above average

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is MERCK Kommanditgesellschaft auf Aktien?

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. The company is listed on the LSE in UK, with a market capitalisation of 24.61B.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (55)

The scoring profile indicates moderate reward potential, with profitability and valuation as the leading contributors. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap24.61B
P/E RatioN/A
Dividend Yield1.22%
52 Week High129.0629
52 Week Low98.7211
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares OutstandingN/A
No. of Employees59,077
IndustryN/A
ExchangeLSE
Beta0.797
CurrencyEUR